See more : Azure Holding Group Corp. (AZRH) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Dian Diagnostics Group Co.,Ltd. (300244.SZ) Income Statement Analysis – Financial Results
- Weaccess Group, Société Anonyme (MLWEA.PA) Income Statement Analysis – Financial Results
- Sitio Royalties Corp. (STR) Income Statement Analysis – Financial Results
- Starzen Company Limited (8043.T) Income Statement Analysis – Financial Results
- Shinhan 13th Special Purpose Acquisition Company (474930.KQ) Income Statement Analysis – Financial Results
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.fosunpharma.com
About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.40B | 43.95B | 39.01B | 30.31B | 28.59B | 24.92B | 18.53B | 14.63B | 12.61B | 12.03B | 10.00B | 7.34B | 6.49B | 4.56B | 3.87B | 3.77B | 3.69B | 3.10B | 2.99B | 2.43B | 2.15B | 1.03B | 727.84M | 579.52M | 442.45M | 340.39M | 190.35M | 92.68M | 64.65M |
| Cost of Revenue | 21.72B | 23.17B | 20.23B | 13.43B | 11.54B | 10.37B | 7.61B | 6.72B | 6.31B | 6.72B | 5.54B | 4.13B | 3.99B | 2.98B | 2.61B | 2.71B | 2.69B | 2.28B | 2.08B | 1.65B | 1.56B | 668.11M | 448.86M | 307.64M | 248.42M | 209.32M | 116.47M | 65.34M | 50.11M |
| Gross Profit | 19.68B | 20.78B | 18.78B | 16.88B | 17.04B | 14.55B | 10.92B | 7.91B | 6.30B | 5.31B | 4.45B | 3.21B | 2.49B | 1.57B | 1.26B | 1.06B | 999.48M | 819.84M | 912.49M | 773.58M | 590.55M | 363.55M | 278.99M | 271.88M | 194.03M | 131.07M | 73.88M | 27.34M | 14.55M |
| Gross Profit Ratio | 47.54% | 47.28% | 48.14% | 55.68% | 59.62% | 58.40% | 58.94% | 54.07% | 49.97% | 44.13% | 44.55% | 43.78% | 38.46% | 34.48% | 32.58% | 28.13% | 27.06% | 26.43% | 30.53% | 31.89% | 27.41% | 35.24% | 38.33% | 46.92% | 43.85% | 38.51% | 38.81% | 29.50% | 22.50% |
| Research & Development | 4.37B | 4.30B | 3.83B | 2.80B | 2.04B | 1.48B | 1.03B | 714.75M | 670.04M | 564.22M | 437.61M | 306.03M | 189.43M | 119.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.37B | 988.06M | 846.11M | 944.68M | 871.54M | 699.89M | 613.13M | 646.76M | 433.95M | 395.71M | 325.91M | 295.80M | 287.62M | 190.82M | 439.71M | 425.78M | 331.43M | 362.36M | 375.95M | 311.08M | 238.31M | 120.49M | 89.08M | 72.04M | 46.07M | 27.22M | 13.00M | 5.91M | 1.80M |
| Selling & Marketing | 9.71B | 9.17B | 9.10B | 8.46B | 9.85B | 8.49B | 5.79B | 3.70B | 2.82B | 2.30B | 1.84B | 1.51B | 1.21B | 798.27M | 636.51M | 496.16M | 485.15M | 417.93M | 437.21M | 330.80M | 300.67M | 175.58M | 110.17M | 90.41M | 48.42M | 31.42M | 15.11M | 4.15M | 431.72K |
| SG&A | 14.20B | 10.16B | 9.95B | 9.41B | 10.72B | 9.19B | 6.40B | 4.35B | 3.25B | 2.70B | 2.17B | 1.81B | 1.50B | 989.10M | 1.08B | 921.93M | 816.58M | 780.28M | 813.15M | 641.89M | 538.98M | 296.06M | 199.25M | 162.46M | 94.50M | 58.64M | 28.11M | 10.07M | 2.23M |
| Other Expenses | -2.19B | 2.68B | 2.28B | 1.84B | 1.67B | 44.06M | -13.18M | 181.87M | 78.28M | 324.56M | 97.89M | 89.86M | 158.79M | 62.11M | 55.99M | 30.93M | 21.86M | 60.53M | 96.48M | 52.78M | 42.66M | 18.11M | 12.35M | 18.86M | 10.88M | 7.98M | 10.01M | -288.06K | 541.13K |
| Operating Expenses | 16.50B | 17.15B | 16.06B | 14.05B | 14.43B | 12.19B | 8.62B | 6.17B | 4.83B | 4.11B | 3.34B | 2.62B | 2.15B | 1.39B | 1.10B | 939.71M | 834.46M | 794.58M | 829.47M | 658.21M | 549.39M | 304.12M | 206.87M | 172.32M | 102.25M | 62.60M | 31.59M | 14.27M | 4.90M |
| Cost & Expenses | 38.09B | 40.31B | 36.28B | 27.48B | 25.97B | 22.55B | 16.23B | 12.89B | 11.14B | 10.83B | 8.88B | 6.75B | 6.14B | 4.38B | 3.71B | 3.65B | 3.53B | 3.08B | 2.91B | 2.31B | 2.11B | 972.23M | 655.73M | 479.95M | 350.67M | 271.92M | 148.06M | 79.61M | 55.01M |
| Interest Income | 327.48M | 282.63M | 233.73M | 199.61M | 186.65M | 145.74M | 79.22M | 80.90M | 56.25M | 69.76M | 63.85M | 29.70M | 51.58M | 19.60M | 14.47M | 17.92M | 12.49M | 13.77M | 17.53M | 13.73M | 8.67M | 2.89M | 13.69M | 8.08M | 0.00 | 0.00 | -0.27 | -0.82 | -0.66 |
| Interest Expense | 1.32B | 963.81M | 822.53M | 880.95M | 1.07B | 929.66M | 577.54M | 488.17M | 470.01M | 415.04M | 350.45M | 370.60M | 313.98M | 162.38M | 132.39M | 149.59M | 130.58M | 83.29M | 72.03M | 37.02M | 45.92M | 36.17M | 23.73M | 9.76M | 0.00 | 0.00 | 3.05M | 3.04M | 1.48M |
| Depreciation & Amortization | 2.97B | 2.34B | 1.83B | 1.67B | 1.47B | 1.32B | 938.59M | 732.90M | 649.34M | 558.41M | 415.53M | 286.20M | 209.90M | 152.66M | 134.69M | 132.46M | 136.49M | 132.06M | 116.69M | 91.15M | 56.06M | 37.60M | 28.57M | 28.13M | 20.07M | 9.25M | -6.98M | 3.27M | 952.86K |
| EBITDA | 7.55B | 7.87B | 8.70B | 6.89B | 7.07B | 3.55B | 5.56B | 4.79B | 4.49B | 3.69B | 3.08B | 2.78B | 2.25B | 1.52B | 3.53B | 1.12B | 1.02B | 556.34M | 458.03M | 441.05M | 445.10M | 248.85M | 212.95M | 154.06M | 120.15M | 74.67M | 42.33M | 13.07M | 9.65M |
| EBITDA Ratio | 18.25% | 24.19% | 23.84% | 22.74% | 27.59% | 23.08% | 29.99% | 33.29% | 36.22% | 33.57% | 37.36% | 38.64% | 37.37% | 34.52% | 92.49% | 30.24% | 27.79% | 17.93% | 15.33% | 18.18% | 20.88% | 24.12% | 28.16% | 32.82% | 25.33% | 22.83% | 22.22% | 14.10% | 14.92% |
| Operating Income | 3.31B | 8.30B | 6.31B | 4.72B | 6.41B | 3.54B | 4.07B | 3.40B | 3.30B | 2.39B | 2.82B | 2.04B | 1.58B | 1.14B | 3.21B | 807.56M | 736.69M | 347.14M | 234.45M | 298.19M | 329.41M | 168.50M | 144.07M | 141.90M | 106.33M | 77.34M | 49.27M | 9.80M | 8.69M |
| Operating Income Ratio | 7.99% | 18.88% | 16.19% | 15.58% | 22.44% | 14.19% | 21.99% | 23.24% | 26.15% | 19.91% | 28.20% | 27.74% | 24.37% | 25.04% | 82.95% | 21.40% | 19.95% | 11.19% | 7.85% | 12.29% | 15.29% | 16.33% | 19.79% | 24.49% | 24.03% | 22.72% | 25.88% | 10.58% | 13.44% |
| Total Other Income/Expenses | -42.94M | -82.27M | -259.90M | -43.30M | -1.89B | 44.06M | -13.18M | 177.21M | 74.66M | 323.71M | -505.22M | 1.53B | 146.16M | 61.50M | 52.64M | 28.12M | 19.69M | -6.15M | 34.85M | 14.69M | 18.43M | 6.58M | 16.58M | -15.26M | 9.73M | 2.15M | -175.57K | -65.24K | 22.76K |
| Income Before Tax | 3.26B | 4.57B | 6.05B | 4.68B | 4.53B | 3.58B | 4.06B | 3.57B | 3.37B | 2.72B | 2.91B | 2.12B | 1.73B | 1.20B | 3.26B | 835.68M | 756.37M | 340.98M | 269.30M | 312.88M | 347.85M | 175.08M | 152.68M | 151.44M | 110.91M | 79.49M | 49.25M | 9.74M | 8.72M |
| Income Before Tax Ratio | 7.89% | 10.41% | 15.52% | 15.43% | 15.83% | 14.37% | 21.92% | 24.41% | 26.74% | 22.60% | 29.07% | 28.92% | 26.62% | 26.39% | 84.31% | 22.15% | 20.48% | 10.99% | 9.01% | 12.90% | 16.14% | 16.97% | 20.98% | 26.13% | 25.07% | 23.35% | 25.88% | 10.51% | 13.48% |
| Income Tax Expense | 369.50M | 626.92M | 1.07B | 737.86M | 782.23M | 559.71M | 476.46M | 350.21M | 501.17M | 348.21M | 506.32M | 283.76M | 341.82M | 201.61M | 700.40M | 74.74M | 66.19M | 48.15M | 31.36M | 30.85M | 49.63M | 13.56M | 11.60M | 15.65M | 16.48M | 12.92M | 9.06M | 3.36M | 2.74M |
| Net Income | 2.39B | 3.73B | 4.73B | 3.66B | 3.32B | 2.71B | 3.12B | 2.81B | 2.46B | 2.11B | 2.03B | 1.56B | 1.17B | 863.65M | 2.50B | 690.86M | 625.78M | 259.16M | 159.03M | 215.33M | 263.62M | 147.21M | 135.52M | 128.52M | 92.16M | 63.73M | 36.03M | 6.38M | 5.98M |
| Net Income Ratio | 5.76% | 8.49% | 12.12% | 12.09% | 11.62% | 10.87% | 16.86% | 19.18% | 19.51% | 17.57% | 20.28% | 21.30% | 17.97% | 18.96% | 64.52% | 18.31% | 16.94% | 8.35% | 5.32% | 8.88% | 12.24% | 14.27% | 18.62% | 22.18% | 20.83% | 18.72% | 18.93% | 6.88% | 9.25% |
| EPS | 0.89 | 1.43 | 1.85 | 1.43 | 1.30 | 1.07 | 1.27 | 1.21 | 1.07 | 0.92 | 0.71 | 0.80 | 0.61 | 0.46 | 1.35 | 0.37 | 0.34 | 0.15 | 0.10 | 0.13 | 0.17 | 0.10 | 0.10 | 0.07 | 0.07 | 0.04 | 0.02 | 0.00 | 0.00 |
| EPS Diluted | 0.89 | 1.43 | 1.85 | 1.43 | 1.30 | 1.07 | 1.27 | 1.20 | 1.06 | 0.92 | 0.71 | 0.80 | 0.61 | 0.46 | 1.35 | 0.37 | 0.34 | 0.15 | 0.10 | 0.13 | 0.17 | 0.10 | 0.10 | 0.07 | 0.07 | 0.04 | 0.02 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 2.68B | 2.61B | 2.56B | 2.56B | 2.56B | 2.52B | 2.46B | 2.32B | 2.30B | 2.30B | 2.23B | 1.95B | 1.91B | 1.88B | 1.85B | 1.85B | 1.84B | 1.70B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B |
| Weighted Avg Shares Out (Dil) | 2.67B | 2.61B | 2.56B | 2.56B | 2.56B | 2.53B | 2.46B | 2.34B | 2.32B | 2.30B | 2.25B | 1.95B | 1.91B | 1.88B | 1.86B | 1.85B | 1.84B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B | 1.76B |
No news found for: 2196.HK
Source: https://incomestatements.info
Category: Stock Reports